Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GE Healthcare’s 2012 Cell Imaging Competition - Voting Opens to Celebrate Art, Science and Discovery

Published: Thursday, November 22, 2012
Last Updated: Thursday, November 22, 2012
Bookmark and Share
Competition features both high-content analysis and high- and super-resolution microscopy cell images for the first time.

GE Healthcare Life Sciences announced that voting for the 2012 Cell Imaging Competition is now open at gelifesciences.com/cellimagecompetition.

Scientists and the wider public are invited to choose their favourite image in two shortlist categories – high-content analysis and high- and super-resolution microscopy – chosen from images submitted by researchers worldwide. Their selection can be made on any basis, whether it is the beauty of the image, the type of research involved, or the technical skills required to generate it. The winners will be invited to see their images displayed on NBC’s high definition screen in Times Square, New York.

The judging panel which shortlists the images is drawn from past winners, academia, editors of peer reviewed journals, and GE scientists. This year the panel comprised:

•    Dr Christine Nybo, Assistant Editor, BioTechniques
•    Dr Julian Heath, Editor, Microscopy & Analysis
•    Dr Leslie Caron, Research Scientist, Genea Stem Cells (and a winner in 2011)
•    Dr Nick Thomas, Principal Scientist, Cell Technologies, GE Healthcare
•    Dr Paul Goodwin, Science Director, Applied Precision, part of Cell Technologies, GE Healthcare

Dr Amr Abid, General Manager of Cell Technologies, GE Healthcare Life Sciences, said, “High-content and super-resolution cell imaging are pioneering technologies that help scientists explore the universe of the cell, to better understand complex cellular mechanisms, and advance the understanding of disease processes. Whether it is the aesthetics or the science that draws people in, we hope that both scientists and the wider public will be inspired and informed by this year’s images.”

View the shortlisted images and vote for your favourite at www.gelifesciences.com/cellimagecompetition


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GE Healthcare to Invest $1 Billion in New Oncology Solutions
Expanding advanced cancer diagnostic and molecular imaging capabilities.
Saturday, September 17, 2011
The Inaugural Winner of GE Healthcare High-Content Analysis (HCA) Award Achieved 20-Fold Increase in Throughput
The inaugural winner of the first GE Healthcare HCA Award has been announced. Supported by BioTechniques, the Award recognizes the outstanding contribution of HCA to scientific understanding and celebrates its positive impact on data quality and quantity, resulting in increased productivity, deeper insights and better decisions.
Friday, October 29, 2010
GE Healthcare to Host DiPIA 2010 - Developments in Protein Interaction Analysis
Addressing functional characterization of proteins and their interactions.
Thursday, July 22, 2010
GE Healthcare Launches High Content Analysis Award
The award recognizes the work of researchers using GE Healthcare’s IN Cell Analyzer.
Tuesday, May 04, 2010
IN Cell Image Competition 2009/2010 Voting Opens
Vote for your favorite image and receive a complementary 2010 calendar!
Tuesday, December 01, 2009
GE Healthcare Forms Strategic Alliance with FUJIFILM in Life Sciences
GE Healthcare announced that it has entered into a Strategic Alliance Agreement with FUJIFILM Corporation. Under the alliance, Fujifilm will develop, manufacture and supply advanced biomolecular imaging systems to GE Healthcare.
Thursday, May 28, 2009
Winners of GE Healthcare’s IN Cell Image Competition Announced
Each of the three winners, from Asia, Europe and North America, will be rewarded with a trip to New York City in March.
Wednesday, January 14, 2009
Scientific News
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!